DK0681470T3 - Composition of recombinant live subunit vaccine and method of preparation thereof - Google Patents

Composition of recombinant live subunit vaccine and method of preparation thereof

Info

Publication number
DK0681470T3
DK0681470T3 DK94905751.7T DK94905751T DK0681470T3 DK 0681470 T3 DK0681470 T3 DK 0681470T3 DK 94905751 T DK94905751 T DK 94905751T DK 0681470 T3 DK0681470 T3 DK 0681470T3
Authority
DK
Denmark
Prior art keywords
preparation
composition
subunit vaccine
recombinant live
recombinant
Prior art date
Application number
DK94905751.7T
Other languages
Danish (da)
Inventor
Vincent Ganne
Original Assignee
S E P P I C Societe Dexploitat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S E P P I C Societe Dexploitat filed Critical S E P P I C Societe Dexploitat
Application granted granted Critical
Publication of DK0681470T3 publication Critical patent/DK0681470T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
DK94905751.7T 1993-01-29 1994-01-28 Composition of recombinant live subunit vaccine and method of preparation thereof DK0681470T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9300942A FR2700957B1 (en) 1993-01-29 1993-01-29 Composition of a live recombinant subunit vaccine and method of preparation.

Publications (1)

Publication Number Publication Date
DK0681470T3 true DK0681470T3 (en) 1996-08-12

Family

ID=9443503

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94905751.7T DK0681470T3 (en) 1993-01-29 1994-01-28 Composition of recombinant live subunit vaccine and method of preparation thereof

Country Status (8)

Country Link
EP (1) EP0681470B1 (en)
JP (2) JPH08505866A (en)
CA (1) CA2154902A1 (en)
DE (1) DE69400312T2 (en)
DK (1) DK0681470T3 (en)
ES (1) ES2089923T3 (en)
FR (1) FR2700957B1 (en)
WO (1) WO1994016681A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707896B1 (en) * 1993-07-22 1995-09-01 Chemoxal Sa Process for treating an article and new aqueous solution of hydrogen peroxide.
FR2717694B1 (en) * 1994-03-22 1996-05-03 Seppic Sa A composition comprising a recombinant plasmid and its uses as a vaccine and medicament.
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2754715B1 (en) * 1996-10-18 1998-11-13 Seppic Sa ADJUVANT, ESPECIALLY IN THE FORM OF AN EMULSION CONTAINING A TRIVALENT METAL CATION AND VACCINE COMPOSITION COMPRISING SAME
US5849303A (en) * 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
FR2754182B1 (en) * 1996-10-07 1998-11-06 Seppic Sa NOVEL VACCINE COMPOSITIONS COMPRISING AS ADJUVANT A SYMPATHOMIMETIC COMPOUND
UA78180C2 (en) 1997-10-03 2007-03-15 Меріаль Porcine circovirus, vaccines and diagnostic reagents
FR2775601B1 (en) * 1998-03-03 2001-09-21 Merial Sas RECOMBINANT LIVING VACCINES AND ADJUVANTS
FR2800280B1 (en) 1999-10-29 2003-09-19 Seppic Sa NOVEL VACCINE COMPOSITION AND USE OF SURFACTANTS AS IMMUNITY ADJUVANTS
FR2809961B1 (en) * 2000-06-09 2004-12-03 Seppic Sa USE OF SUGAR ETHERS AS IMMUNITY ADDITIVES IN VACCINE COMPOSITIONS, THERAPEUTIC COMPOSITIONS CONTAINING THEM AND THEIR USE AS VACCINES
JP2002030098A (en) * 2000-07-17 2002-01-29 Institute Of Immunology Co Ltd Method for recovering virion envelope from budded virus of baculovirus
FR2814956B1 (en) * 2000-10-06 2003-01-24 Seppic Sa NOVEL VACCINE COMPOSITION, PROCESS FOR ITS PREPARATION, USE AS AN INJECTAL COMPOSITION IN HUMAN OR VETERINARY MEDICINE AND NEW METHOD OF PRESERVATION
WO2002062381A1 (en) * 2001-02-05 2002-08-15 Hisamitsu Pharmaceutical Co., Inc. Baculovirus vector vaccine
CN102294023A (en) * 2001-07-26 2011-12-28 奥塔戈创新公司 Antigenic compositions
AU2008202282B8 (en) * 2001-07-26 2009-08-13 Agresearch Limited Immunogenic Compositions
WO2003020322A1 (en) * 2001-09-04 2003-03-13 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Vector used to induce an immune response
FR2922767B1 (en) 2007-10-24 2009-12-18 Seppic Sa PROCESS FOR PREPARING A VACCINE COMPOSITION COMPRISING AT LEAST ONE ANTIGEN AND AT LEAST ONE ADJUVANT

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8301996A (en) * 1983-06-06 1985-01-02 Duphar Int Res METHOD FOR PREPARING ADVISED LIVE VACCINES AND SO OBTAINED VACCINES OBTAINED.
FR2649013B1 (en) * 1989-07-03 1991-10-25 Seppic Sa VACCINES AND VECTORS OF FLUID ACTIVE INGREDIENTS CONTAINING METABOLIZABLE OIL
WO1992011028A1 (en) * 1990-12-19 1992-07-09 Epitope, Inc. Hiv reverse transcriptase vaccine

Also Published As

Publication number Publication date
FR2700957B1 (en) 1995-03-03
JP2004137283A (en) 2004-05-13
EP0681470A1 (en) 1995-11-15
CA2154902A1 (en) 1994-08-04
DE69400312D1 (en) 1996-08-22
ES2089923T3 (en) 1996-10-01
EP0681470B1 (en) 1996-07-17
JPH08505866A (en) 1996-06-25
WO1994016681A1 (en) 1994-08-04
DE69400312T2 (en) 1996-11-21
FR2700957A1 (en) 1994-08-05

Similar Documents

Publication Publication Date Title
DK0681470T3 (en) Composition of recombinant live subunit vaccine and method of preparation thereof
DK0861089T3 (en) Methods and compositions for administration of monomeric proteins
DK0622408T3 (en) Composition and process for the preparation of gelatin-free soft capsules
NO973046D0 (en) Elastic cement compositions and methods
NO973632D0 (en) Curing retarded cement compositions and methods for their preparation
NO933434D0 (en) PIPERIDE INGREDIENTS, THEIR PREPARATION AND USE
IS1850B (en) Crystalline poly-synthetic image of an indole derivative, its use, method of preparation and drug formulations
DK0858329T3 (en) New stable, liquid acetaminophen preparations and methods for their preparation
NO964583D0 (en) Lightweight well cement compositions and methods
DK0954588T3 (en) OB fusion protein compositions and methods
DK0946190T3 (en) Methods and Compositions for Stimulating Neurite Growth
DK0500807T3 (en) Composition and method of wetting tissue
DK0797431T3 (en) Aerosol formulations of peptides and proteins
DK0544687T3 (en) Hearing aid and method for its preparation
NO922275L (en) ARYLETERS, THEIR PREPARATION AND PROCEDURE FOR TREATMENT
ID17860A (en) VACCINE COMPOSITION
DK44891D0 (en) PARTICULAR MINERAL SALT COMPOSITION AND PROCEDURE FOR PREPARING SAME
DK0384323T3 (en) Composition and method for enhancing the effect of a fishing vaccine
DK0884358T3 (en) Flexible and impactful compositions based on polyvinylidene fluoride and process for their preparation
DK10288A (en) PROCEDURE FOR ISOLATING AND CLEANING P. FALCIPARUM CS PROTEIN INVACCINE EXPRESSED IN RECOMBINATED E. COLI
DK60893D0 (en) PIPERIDE INGREDIENTS, THEIR PREPARATION AND USE
DK0970077T3 (en) Improved process for the preparation of thiazolidinediones and novel thiazolidinediones
NO933435D0 (en) PIPERIDE INGREDIENTS, THEIR PREPARATION AND USE
DK147492D0 (en) PROCEDURE AND PLANT FOR MANUFACTURING CEMENT CLINKS
DK1131414T3 (en) Stable, attenuated rabies virus mutants and live vaccines thereof